✦ LIBER ✦

Paclitaxel, gemcitabine, and cisplatin in non-resectable, non-small cell lung cancer (NSCLC)

✍ Scribed by Sorensen, Jens B.; Stenbygaard, Lars Erik; Osterlind, Kell; Hansen, Heine Høi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine in Non-Small Cell Lung Cance

✍ Christian Manegold; Petr Zatloukal; Kurt Krejcy; Johannes Blatter 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 116 KB

O-111 Neoadjuvant gemcitabine and pemetr

✍ Bepler, G.; Sommers, E.; Robinson, L.; Sharma, A.; Cantor, A.; Williams, C.; Chi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Ifosfamide and gemcitabine in advanced n

✍ Gatzemeier, O.; Manegold, C.; Eberhard, W.; Wilke, H.; Chomy, F.; Chomy, P.; Kha 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Gemcitabine—cisplatin combination in met

✍ Merimsky, O; Wigler, N; Schwarz, Y; Greif, Y; Mann, A; Inbar, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Gemcitabine, ifosfamide and cisplatin in

✍ Wu, M.-F; Tsai, C.-M; Wu, T.-C; Tsao, S.-M; Wu, M.-H; Chern, M.-S; Su, J.-M; Cho 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB